Cortrosyn is a Intramuscular; Intravenous; Parenteral Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Henry Schein, Inc.. The primary component is Cosyntropin.
Product ID | 0404-9839_1261064a-58c8-42cc-8058-90b434dd8eb8 |
NDC | 0404-9839 |
Product Type | Human Prescription Drug |
Proprietary Name | Cortrosyn |
Generic Name | Cortrosyn |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
Marketing Start Date | 2022-01-09 |
Marketing Category | NDA / |
Application Number | NDA016750 |
Labeler Name | Henry Schein, Inc. |
Substance Name | COSYNTROPIN |
Active Ingredient Strength | 0 mg/mL |
Pharm Classes | Adrenocorticotropic Hormone [CS],Adrenocorticotropic Hormone [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-01-09 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0404-9839 | Cortrosyn | Cortrosyn |
0548-5900 | Cortrosyn | Cosyntropin |
50090-4547 | Cortrosyn | Cosyntropin |
52584-050 | Cortrosyn | Cortrosyn |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CORTROSYN 78761920 3165133 Live/Registered |
Amphastar Pharmaceuticals, Inc. 2005-11-28 |
CORTROSYN 72186267 0779366 Dead/Expired |
ORGANON INC. 1964-02-07 |